Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;63(5):1565-1579.
doi: 10.1007/s00394-024-03422-x. Epub 2024 May 10.

Fish oil supplementation during pregnancy decreases liver endocannabinoid system and lipogenic markers in newborn rats exposed to maternal high-fat diet

Larissa B Fassarella #  1 , Jessika G O Neto #  1 , Juliana Woyames  1 , Gustavo R C Santos  2 , Henrique M G Pereira  2 , Carmen C Pazos-Moura #  1 , Isis H Trevenzoli #  3
Affiliations

Fish oil supplementation during pregnancy decreases liver endocannabinoid system and lipogenic markers in newborn rats exposed to maternal high-fat diet

Larissa B Fassarella et al. Eur J Nutr. 2024 Aug.

Abstract

Purpose: Maternal high-fat diet (HF) programs obesity, metabolic dysfunction-associated steatotic liver disease (MASLD), hypertriglyceridemia, and hyperglycemia associated with increased endocannabinoid system (ECS) in the liver of adult male rat offspring. We hypothesized that maternal HF would induce sex specific ECS changes in the liver of newborn rats, prior to obesity onset, and maternal fish oil (FO) supplementation would reprogram the ECS and lipid metabolism markers preventing liver triglycerides (TG) accumulation.

Methods: Female rats received a control (CT) (10.9% fat) or HF (28.7% fat) diet 8 weeks prior to mating and during pregnancy. A subgroup of HF dams received 3% FO supplementation in the HF diet (35.4% fat) during pregnancy (HFFO). Serum hormones and liver TG, ECS, lipid metabolism, oxidative stress and autophagy markers were assessed in male and female newborn offspring.

Results: Maternal HF diet increased liver cannabinoid receptor 1 (CB1) in males and decreased CB2 in females, with no effect on liver TG. Maternal FO supplementation reduced liver CB1 regardless of the offspring sex, but reduced TG liver content only in females. FO reduced the liver content of the endocannabinoid anandamide in males, and the content of 2-arachidonoylglycerol in both sexes. Maternal HF increased lipogenic and decreased lipid oxidation markers, and FO induced the opposite regulation in the liver of offspring.

Conclusion: Prenatal HF and FO differentially modulate liver ECS in the offspring before obesity and MASLD development. These results suggest that maternal nutrition at critical stages of development can modulate the offspring's ECS, predisposing or preventing the onset of metabolic diseases.

Keywords: Endocannabinoid system; Fish oil; Maternal high-fat diet; Metabolic programming; Non-alcoholic fatty liver disease; Obesity.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Di Marzo V, Silvestri C (2019) Lifestyle and metabolic syndrome: contribution of the endocannabinoidome. Nutrients. https://doi.org/10.3390/nu11081956 - DOI - PubMed - PMC
    1. Roger C, Buch C, Muller T, Leemput J, Demizieux L, Passilly-Degrace P, Cinar R, Iyer MR, Kunos G, Verges B, Degrace P, Jourdan T (2020) Simultaneous inhibition of peripheral CB1R and iNOS mitigates obesity-related dyslipidemia through distinct mechanisms. Diabetes 69(10):2120–2132. https://doi.org/10.2337/db20-0078 - DOI - PubMed - PMC
    1. Freitas HR, Isaac AR, Malcher-Lopes R, Diaz BL, Trevenzoli IH, De Melo Reis RA (2017) Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutr Neurosci. https://doi.org/10.1080/1028415X.2017.1347373 - DOI - PubMed
    1. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, Hansen SH, Hansen HS (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochem Biophys Acta 1781(4):200–212. https://doi.org/10.1016/j.bbalip.2008.01.006 - DOI - PubMed
    1. Veilleux A, Di Marzo V, Silvestri C (2019) The expanded endocannabinoid system/endocannabinoidome as a potential target for treating diabetes mellitus. Curr DiabRep 19(11):117. https://doi.org/10.1007/s11892-019-1248-9 - DOI

MeSH terms

LinkOut - more resources